SCHEMBL1634153

SCHEMBL1634153

CC(=O)Nc1cc(NC(C)=O)cc(Nc2ncc3c(Cl)ccc(OC4CCNCC4)c3n2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.47
JAK1 P23458 2/20 0.47
TYK2 P29597 2/20 0.47
JAK3 P52333 2/20 0.47
RORC P51449 1/20 0.46
IGF1R P08069 2/20 0.39
PTK2 Q05397 1/20 0.39
PAICS P22234 2/20 0.38
SCN9A Q15858 1/20 0.38
EGFR P00533 2/20 0.38
ITK Q08881 1/20 0.38
FLT3 P36888 1/20 0.37
TNIK Q9UKE5 1/20 0.37
IRAK4 Q9NWZ3 2/20 0.37
IRAK1 P51617 1/20 0.37
CHEK1 O14757 1/20 0.37
AURKA O14965 1/20 0.37
AURKB Q96GD4 1/20 0.37
SYK P43405 1/20 0.37
MAP3K5 Q99683 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13498253 0.95 JAK2 (0.43) JAK2JAK1TYK2JAK3RORC
SCHEMBL1634969 0.83 JAK2 (0.44) JAK2JAK1TYK2JAK3PTK2
SCHEMBL12724549 0.81 JAK2 (0.50) JAK2JAK1TYK2JAK3IGF1R
SCHEMBL1632909 0.81 TBK1 (0.53) JAK2JAK1TYK2JAK3PTK2
SCHEMBL1632937 0.80 PTK2 (0.51) JAK2JAK1TYK2JAK3PTK2
SCHEMBL1633937 0.80 JAK2 (0.53) JAK2JAK1TYK2JAK3IGF1R
SCHEMBL1632769 0.80 SYK (0.40) JAK2JAK1TYK2JAK3PTK2
SCHEMBL12764435 0.80 JAK2 (0.50) JAK2JAK1TYK2JAK3IGF1R
SCHEMBL3465389 0.80 JAK2 (0.46) JAK2JAK1TYK2JAK3IGF1R
SCHEMBL1634717 0.80 JAK2 (0.50) JAK2JAK1TYK2JAK3SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed